Pharmacological Chaperoning: A Potential Treatment for PMM2-CDG. (Q36172720)

12 August 2017

Pharmacological Chaperoning: A Potential Treatment for PMM2-CDG. (English)

1 reference

12 August 2017

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Aurora Martinez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Patricia Yuste-Checa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Sandra Brasil

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Alejandra Gámez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Lourdes R Desviat

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Magdalena Ugarte

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Celia Pérez-Cerdá

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Belén Pérez

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

publication date

24 October 2016

1 reference

12 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

160-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Pharmacological chaperones for enzyme enhancement therapy in genetic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Chemistry: Chemical con artists foil drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Identification and evaluation of molecular properties related to preclinical optimization and clinical fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Chemical and biological properties of frequent screening hits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

The essential roles of chemistry in high-throughput screening triage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Enzyme replacement and enhancement therapies: lessons from lysosomal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Solving glycosylation disorders: fundamental approaches reveal complicated pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Strategic Pooling of Compounds for High-Throughput Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Congenital disorders of glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Pharmacological chaperones as a potential therapeutic option in methylmalonic aciduria cblB type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Chemical and biological approaches synergize to ameliorate protein-folding diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Pharmacokinetically based mapping device for chemical space navigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

The molecular landscape of phosphomannose mutase deficiency in iberian peninsula: identification of 15 population-specific mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Biological and chemical approaches to diseases of proteostasis deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Successful prenatal mannose treatment for congenital disorder of glycosylation-Ia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Rescue of misfolded proteins and stabilization by small molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Protein production by auto-induction in high density shaking cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Targeted disruption of the mouse phosphomannomutase 2 gene causes early embryonic lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

The Effects of PMM2-CDG-Causing Mutations on the Folding, Activity, and Stability of the PMM2 Protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

7 January 2021

Small molecules that target protein misfolding

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

7 January 2021

Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia)

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

7 January 2021

Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.23138

7 January 2021

Identifiers

DOI

10.1002/HUMU.23138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27774737%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference